Literature DB >> 7009839

Etiology and treatment of occlusal pathosis and associated facial pain.

J P Okeson.   

Abstract

The treatment of occlusal pathosis and associated facial pain is a difficult and complex problem. The interaction of two etiologic factors, occlusal interferences and psychologic stress, results in parafunctional activity. The most important prerequisite to selection of a treatment method is an understanding of the etiology of the problem. What dentistry needs is a mechanism by which the major etiologic factor of parafunctional activity can be identified for each patient. Treatment can then be directed toward the reduction or elimination of that factor. When treatment is directed toward the major cause of the problem, the likelihood of success will increase greatly. Continued research on this problem will yield new insights and means for the accurate determination of the etiology of parafunctional activity for each patient.

Entities:  

Mesh:

Year:  1981        PMID: 7009839     DOI: 10.1016/0022-3913(81)90340-1

Source DB:  PubMed          Journal:  J Prosthet Dent        ISSN: 0022-3913            Impact factor:   3.426


  4 in total

1.  Atypical orofacial pain disorders: a study of diagnostic subtypes.

Authors:  J R Fricton
Journal:  Curr Rev Pain       Date:  2000

2.  Bibliography for the control of anxiety, fear and pain in dentistry.

Authors:  G L McAlister; C L Richardson
Journal:  Anesth Prog       Date:  1982 Nov-Dec

3.  Randomized clinical study of wear of enamel antagonists against polished monolithic zirconia crowns.

Authors:  J F Esquivel-Upshaw; M J Kim; S M Hsu; N Abdulhameed; R Jenkins; D Neal; F Ren; A E Clark
Journal:  J Dent       Date:  2017-10-16       Impact factor: 4.379

4.  Three years in vivo wear: core-ceramic, veneers, and enamel antagonists.

Authors:  Josephine F Esquivel-Upshaw; William F Rose; Allyson A Barrett; Erica R Oliveira; Mark C K Yang; Arthur E Clark; Kenneth J Anusavice
Journal:  Dent Mater       Date:  2012-03-10       Impact factor: 5.304

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.